HSCT in 2024: What Every Hematologist Needs to Know

Find latest Myeloma videos · 500+ videos

HSCT in 2024: What Every Hematologist Needs to Know

By Indy Hematology Review FEATURING Richard Childs

874 views

April 18, 2024

Comments 0

ASH 2024 Summary: Highlights in AML, MDS, and ALL

2024 ASH Annual Meeting Insights Hub

T. Badar

1.3K views

ASH 2024 Review: Key Multiple Myeloma Abstracts

Cleveland Clinic Taussig Cancer Institute

N. Callander

426 views

ASH 2024 Summary: Menin Inhibitors in AML - FDA Approval and Highlig…

2024 ASH Annual Meeting Insights Hub

J. Zeidner

446 views

Why Are Our Hematopoietic Stem Cells in the Bone Marrow?

Louisville Hematology Highlights

R. Gale

4.8K views

Multiple Myeloma: A Journey From Pharaoh's Times to 2024

Houston Methodist

S. Ganguly

368 views

ASH 2024 Summary: Transplant Options and Outcomes for TP53 Myeloid D…

2024 ASH Annual Meeting Insights Hub

H. Fernandez

257 views

Experts Discuss the Pathophysiology, Diagnosis, and Treatment of BPD…

MyCancerHaven

R. Vij, G. Murthy

706 views

Myeloid Malignancies: Hot Topics in 2024

Yale Cancer Center

N. Podoltsev

394 views

AML, MDS, and CML Highlights & Key Takeaways From ASCO®/EHA 2024

Insights from 2024 EHA Annual Meeting

T. Badar

826 views

ASH 2024 Summary: Transplant in Myeloma - Key Factors in Decision-Ma…

2024 ASH Annual Meeting Insights Hub

A. Perrot

179 views

Advancements in AML Management in 2024

Louisville Hematology Highlights

C. Lachowiez

207 views

New

Revumenib for KMT2A+ R/R Acute Leukemias - Drug Overview and Clinica…

OncoPharm

J. Bossaer

20 views

ASH 2024 Review: Updates on the Management of MDS

Cleveland Clinic Taussig Cancer Institute

H. Carraway

140 views

ESMO 2024 Summary: Highlights in Heme Malignancies

2024 ESMO Annual Meeting Insights Hub

M. Gomes da Silva

587 views

Cellular Therapies for Myeloid Malignancies

Moffitt Cancer Center

D. Sallman

138 views

Debate: There Is a Role for Anti-Inflammatory Treatment in MDS

MDS Foundation

L. Weeks

108 views

Understanding the NPM1 Mutation in AML: Dr. Jekyll and Mr. Hyde

SOHO Brazil 2024

J. Lancet

598 views

New

Understanding the AML Disease State: Key Challenges and Advances

Cleveland Clinic Taussig Cancer Institute

M. Mustafa Ali

113 views

New

The Future of NDMM Treatment: Ongoing Trials and Key ASH 2024 Oral A…

University of Miami Sylvester Comprehensive Cancer Center

O. Landgren

97 views

Login

Login

Join VuMedi

HSCT in 2024: What Every Hematologist Needs to Know

Related Videos

A proven CD123 targeted therapy for BPDCN

ASH 2024 Summary: Highlights in AML, MDS, and ALL

ASH 2024 Review: Key Multiple Myeloma Abstracts

ASH 2024 Summary: Menin Inhibitors in AML - FDA Approval and Highlig…

Why Are Our Hematopoietic Stem Cells in the Bone Marrow?

Multiple Myeloma: A Journey From Pharaoh's Times to 2024

ASH 2024 Summary: Transplant Options and Outcomes for TP53 Myeloid D…

Experts Discuss the Pathophysiology, Diagnosis, and Treatment of BPD…

Myeloid Malignancies: Hot Topics in 2024

AML, MDS, and CML Highlights & Key Takeaways From ASCO®/EHA 2024

ASH 2024 Summary: Transplant in Myeloma - Key Factors in Decision-Ma…

Advancements in AML Management in 2024

Revumenib for KMT2A+ R/R Acute Leukemias - Drug Overview and Clinica…

ASH 2024 Review: Updates on the Management of MDS

ESMO 2024 Summary: Highlights in Heme Malignancies

Cellular Therapies for Myeloid Malignancies

Debate: There Is a Role for Anti-Inflammatory Treatment in MDS

Understanding the NPM1 Mutation in AML: Dr. Jekyll and Mr. Hyde

Understanding the AML Disease State: Key Challenges and Advances

The Future of NDMM Treatment: Ongoing Trials and Key ASH 2024 Oral A…